Literature DB >> 17027672

Combining motor training with transplantation of rat bone marrow stromal cells does not improve repair or recovery in rats with thoracic contusion injuries.

Hiroyuki Yoshihara1, Jed S Shumsky, Birgit Neuhuber, Takanobu Otsuka, Itzhak Fischer, Marion Murray.   

Abstract

Previous studies have demonstrated that either transplantation of bone marrow stromal cells (MSC) or physical exercise regimens can elicit limited functional recovery following spinal cord injury, presumably through different mechanisms. The present study examined whether transplantation of MSC derived from transgenic Fischer alkaline phosphatase (AP) rats, in combination with exercise, would have synergistic effects leading to recovery of function that is greater than either alone. Adult female Sprague-Dawley rats received a moderate thoracic contusion injury and were divided into three groups: operated controls (Op-Control), MSC transplant recipients (MSC), and MSC transplant recipients plus exercise (MSC+Ex). Nine days after contusion, a Vitrogen matrix +/-one million MSC was injected into the lesion site in all animals. Immunosuppression with high doses of Cyclosporine A, required for MSC survival, was provided for all animals. Passive hindlimb exercise on motorized bicycles was applied 1 h/day, 3 days/week to the MSC+Ex group. A battery of behavioral tests was performed weekly to assess motor and sensory functions in all 3 groups for 12 weeks. Morphological evaluation included MSC survival, evidence of axonal growth into grafts, phenotypic analysis of MSC, and lesion/transplant size. The weight of the medial gastrocnemius muscle, a hindlimb muscle activated during stance, was used to identify extent of atrophy. No differences in motor recovery were found among the three groups. MSC survived 3 months after transplantation, indicating that the immunosuppression treatment was successful. The extent of survival was variable, and there was no correlation between MSC survival and behavioral scores. The matrix persisted, filling the lesion cavity, and some axons grew into the lesion/matrix but to a similar extent in all groups. There was no difference in lesion/matrix size among groups, indicating no neuroprotective effect on the host provided by the treatments. Immunocytochemical analysis provided no evidence that MSC differentiated into neurons, astrocytes or oligodendrocytes. Muscle mass of the medial gastrocnemius was diminished in the Op-Control group indicating significant atrophy, but was partially preserved in both the MSC and MSC+Ex groups. Our results indicate that combining the beneficial effects of rat MSC and this exercise protocol was not sufficient to enhance behavioral recovery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027672     DOI: 10.1016/j.brainres.2006.08.080

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Activity-dependent plasticity in spinal cord injury.

Authors:  James V Lynskey; Adam Belanger; Ranu Jung
Journal:  J Rehabil Res Dev       Date:  2008

2.  Characterization of neuron-like cells derived from canine bone marrow stromal cells.

Authors:  Yasutaka Oda; Kenji Tani; Toshitaka Kanei; Tomoya Haraguchi; Kazuhito Itamoto; Hiroshi Nakazawa; Yasuho Taura
Journal:  Vet Res Commun       Date:  2013-02-23       Impact factor: 2.459

Review 3.  A systematic review of cellular transplantation therapies for spinal cord injury.

Authors:  Wolfram Tetzlaff; Elena B Okon; Soheila Karimi-Abdolrezaee; Caitlin E Hill; Joseph S Sparling; Jason R Plemel; Ward T Plunet; Eve C Tsai; Darryl Baptiste; Laura J Smithson; Michael D Kawaja; Michael G Fehlings; Brian K Kwon
Journal:  J Neurotrauma       Date:  2010-04-20       Impact factor: 5.269

Review 4.  Injured mice at the gym: review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury.

Authors:  Lyn B Jakeman; Emily L Hoschouer; D Michele Basso
Journal:  Brain Res Bull       Date:  2010-06-15       Impact factor: 4.077

5.  Effects of differentiated versus undifferentiated adipose tissue-derived stromal cell grafts on functional recovery after spinal cord contusion.

Authors:  Hong-Tian Zhang; Jie Luo; Li-Sen Sui; Xu Ma; Zhong-Jie Yan; Jian-Hao Lin; Yu-Sheng Wang; Yi-Zhao Chen; Xiao-Dan Jiang; Ru-Xiang Xu
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

6.  Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.

Authors:  Angelo H All; Payam Gharibani; Siddharth Gupta; Faith A Bazley; Nikta Pashai; Bin-Kuan Chou; Sandeep Shah; Linda M Resar; Linzhao Cheng; John D Gearhart; Candace L Kerr
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

7.  Human olfactory mesenchymal stromal cell transplants promote remyelination and earlier improvement in gait co-ordination after spinal cord injury.

Authors:  Susan L Lindsay; Andrew Toft; Jacob Griffin; Ahmed M M Emraja; Susan Carol Barnett; John S Riddell
Journal:  Glia       Date:  2017-02-01       Impact factor: 7.452

Review 8.  Regenerative Rehabilitation and Stem Cell Therapy Targeting Chronic Spinal Cord Injury: A Review of Preclinical Studies.

Authors:  Syoichi Tashiro; Masaya Nakamura; Hideyuki Okano
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

9.  Effects of polyethylene glycol administration and bone marrow stromal cell transplantation therapy in spinal cord injury mice.

Authors:  Yasutaka Oda; Kenji Tani; Atsunobu Isozaki; Tomoya Haraguchi; Kazuhito Itamoto; Hiroshi Nakazawa; Yasuho Taura
Journal:  J Vet Med Sci       Date:  2013-11-22       Impact factor: 1.267

10.  Adipose-Derived Mesenchymal Stem Cell Application Combined With Fibrin Matrix Promotes Structural and Functional Recovery Following Spinal Cord Injury in Rats.

Authors:  Yana O Mukhamedshina; Elvira R Akhmetzyanova; Alexander A Kostennikov; Elena Y Zakirova; Luisa R Galieva; Ekaterina E Garanina; Alexander A Rogozin; Andrey P Kiassov; Albert A Rizvanov
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.